E
Neurogene Inc. NGNE
$17.89 $0.1050.59%
Recommendation
Sell
Prev Close
$17.78
Volume
1,036
Avg Vol (90D)
359,293
Market Cap
$264.12M
Dividend & Yield
--
52-Week Range
$14.42 - $74.49
P/E (TTM)
0.40
EPS (TTM)
$43.96
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Neurogene (NGNE, $17.05) entered Uptrend as Momentum indicator ascends above 0 level on Mar 10, 2025
3/11/2025 - Tickeron - Stocks
Neurogene (NGNE, $17.05) entered Uptrend as Momentum indicator ascends above 0 level on Mar 10, 2025
3/11/2025 - Tickeron - Stocks
IBRN's Underlying Holdings Imply 74% Gain Potential
3/10/2025 - ETF Channel
Neurogene: Potential To Target Root Cause Of Rett Syndrome With NGN-401
3/7/2025 - SeekingAlpha
Neurogene Inc. (NASDAQ:NGNE) Short Interest Update
3/7/2025 - MarketBeat
Neurogene (NGNE, $16.91) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 5, 2025
3/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.91) Stochastic Oscillator left the oversold zone on March 05, 2025
3/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.91) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 5, 2025
3/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.91) Stochastic Oscillator left the oversold zone on March 05, 2025
3/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.91) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 5, 2025
3/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.91) Stochastic Oscillator left the oversold zone on March 05, 2025
3/6/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.35) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 4, 2025
3/5/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.21) Stochastic Oscillator left the oversold zone on March 03, 2025
3/4/2025 - Tickeron - Stocks
Neurogene (NGNE, $17.69) Stochastic Oscillator left the oversold zone on February 28, 2025
3/1/2025 - Tickeron - Stocks
Neurogene (NGNE, $17.2) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 26, 2025
2/27/2025 - Tickeron - Stocks
Neurogene (NGNE, $16.76) Moving Average Convergence Divergence (MACD) Histogram turned negative on February 25, 2025
2/26/2025 - Tickeron - Stocks
Neurogene to Participate in Upcoming Conferences
2/24/2025 - GuruFocus
Neurogene to Participate in Upcoming Conferences
2/24/2025 - Business Wire
Neurogene (NGNE, $16.97) entered Downtrend as Momentum indicator drops below 0 level on Feb 19, 2025
2/20/2025 - Tickeron - Stocks
Neurogene (NGNE, $17.35) Stochastic Oscillator left the oversold zone on February 18, 2025
2/19/2025 - Tickeron - Stocks
Redmile Group, LLC Increases Stake in Neurogene Inc: A Strategic Move in Biotechnology
2/15/2025 - GuruFocus
GREAT POINT PARTNERS LLC Reduces Stake in Neurogene Inc
2/15/2025 - GuruFocus
Neurogene (NGNE, $18.42) Stochastic Oscillator left the oversold zone on February 14, 2025
2/15/2025 - Tickeron - Stocks
Casdin Capital, LLC Increases Stake in Neurogene Inc
2/15/2025 - GuruFocus
RTW INVESTMENTS, LP Increases Stake in Neurogene Inc
2/14/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$925.00K
EBITDA (TTM)
-$72.45M
EBIT (TTM)
-$75.73M
Net Income (TTM)
-$53.25M
Balance Sheet
Total Assets (Q)
$164.12M
Total Debt (Q)
$13.12M
Total Liabilities (Q)
$26.71M
Book Value Per Share (Q)
$10.56
Cash Flow
Cash from Operations (TTM)
-$70.08M
Cash from Investing (TTM)
$3.19M
Cash from Financing (TTM)
$88.30M
Net Change in Cash (TTM)
$21.41M
Filings
Filing Date
Monday, November 18, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
--
7-Day Total Return
9.39%
30-Day Total Return
15.31%
60-Day Total Return
-19.92%
90-Day Total Return
-59.11%
Year to Date Total Return
-21.87%
1-Year Total Return
-50.40%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jan 24, 2025 - $14.42
52-week High
Nov 11, 2024 - $74.49
Valuation
Market Cap
$264.12M - Micro Cap
Enterprise Value
$138.24M
Price/Sales (TTM)
326.24
Price/Book (Q)
1.68
Dividends and Shares
Shares Outstanding
16.95M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.neurogene.com
Phone Number
855 508 3568
Address
535 W 24th Street
New York, NY 10011
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus... more
NASDAQ 03/13/2025 9:40AM Eastern Quotes delayed
Weiss Ratings